(NASDAQ: OCGN) Ocugen's forecast annual revenue growth rate of 62.79% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.22%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.95%.
Ocugen's revenue in 2024 is $7,050,000.On average, 1 Wall Street analysts forecast OCGN's revenue for 2024 to be $257,328,085, with the lowest OCGN revenue forecast at $257,328,085, and the highest OCGN revenue forecast at $257,328,085. On average, 1 Wall Street analysts forecast OCGN's revenue for 2025 to be $10,375,468,387, with the lowest OCGN revenue forecast at $10,375,468,387, and the highest OCGN revenue forecast at $10,375,468,387.
In 2026, OCGN is forecast to generate $5,293,238,708 in revenue, with the lowest revenue forecast at $5,293,238,708 and the highest revenue forecast at $5,293,238,708.